|
|
|
| Influencing factors of the efficacy of the combination of Carboprost Trometham ine and Oxytocin in the treatment of postpartum hemorrhage after cesarean section |
| ZHAO Ya-ling |
| Department of Obstetrics and Gynecology,Chang′an Hospital in Dongguan City,Guangdong Province,Dongguan 523800,China |
|
|
|
|
Abstract ObjectiveTo explore the influencing factors of the efficacy of the combination of Carboprost Tromethamine and Oxytocin in the treatmentofpostpartum hemorrhageaftercesarean section.MethodsA retrospectiveanalysisof140 cases of cesarean section postpartum hemorrhage treated with Carboprost Tromethamine combined with Oxytocin in Chang′an Hospital in Dongguan City of Guangdong Province from September 2015 to September 2017 were carried out.According to the effect of clinical treatment,the patients were divided into effective group(n=120)and ineffective group(n=20).Single factor descriptive analysis and multiple factor Logistic regression analysis of factors that may affect the efficacy of such patients treated with Carboprost Tromethamine and Oxytocin were determined.ResultsThe rates of age≥35 years old,uterine scar pregnancy,multi fetus,fetal distress,double or multiple births,placenta previa,gestational times>3 and small pelvis in the ineffective group were much higher than those in the effective group,the differences were statistically significant(χ2=23.770,61.920,21.672,9.047,4.543,7.426,15.084,P<0.05).The age ≥35 years old,uterine scar pregnancy,multi fetus,fetal distress,double or multiple births,placenta previa,gestational times>3 and small pelvis were independent risk factors affecting the efficacy by Logistic regression analysis(OR=12.475,19.643,11.120,5.407,4.144,4.071,6.745,P<0.05).ConclusionThe greater the age,the less effective the treatment of postpartum hemorrhage treated with Carboprost Tromethamine combined with Oxytocin,in addition,there are a variety of risk factors that are more common.In order to promote the rapid recovery of postpartum hemorrhage in caesarean section and guarantee the recovery of postpartum hemorrhage,the strategies of improving the curative effect should be formulated according to the analysis of the above risk factors.
|
|
|
|
|
|
| [1] |
王瑞姣，韩汝芳，颜杰文，等.缩宫素联合卡前列素氨丁三醇预防高危产妇剖宫产产后出血的效果研究[J].中国妇幼保健，2016，31（15）：3033-3035.
|
| [2] |
于万芹.卡前列素氨丁三醇联合缩宫素在减少凶险性前置胎盘产后出血中的临床效果[J].河北医药，2017，39（12）：1877-1879.
|
| [3] |
杨妍.宫体注射卡前列素氨丁三醇对预防剖宫产产后出血的效果观察[J].中国妇幼保健，2017，32（4）：700-702.
|
| [4] |
潘琴.卡前列素氨丁三醇联合缩宫素在高危妊娠且行剖宫产术中的应用价值分析[J].解放军医药杂志，2017，29（9）：6-8.
|
| [5] |
Caceda SI，Ramos RR，Saborido CM.Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima，Peru[J].J Comp Eff Res，2018，7（1）：49-55.
|
| [6] |
焦丽娜.葡萄糖酸钙联合卡前列素氨丁三醇对高危产妇剖宫产产后出血的预防作用[J].安徽医药，2016，20（11）：2150-2152.
|
| [7] |
劳丹青.卡前列素氨丁三醇联合地塞米松用于剖宫产产后出血患者对SBP、DBP、HR影响及意义分析[J].中国医药导刊，2016，18（1）：69-70.
|
| [8] |
张素兰，冯万成，米岩.卡前列素氨丁三醇在中央型前置胎盘剖宫产术中的应用[J].宁夏医科大学学报，2016，38（6）：705-707.
|
| [9] |
陈红燕，张世昌，陈黎.卡前列素氨丁三醇预防剖宫产后出血高危产妇的临床效果观察[J].重庆医学，2017，46（33）：175-177.
|
| [10] |
Volochovic J，Ramasauskaite D，Simkeviciūte R.Clinical aspects and antenatal diagnosis of invasive placenta：a review of ten-years′experience of a multi-profile hospital in Lithuania[J].Acta Med Litu，2017，24（3）：176-187.
|
| [11] |
李洪书，覃春艳，余卢妹.预防性宫体注射卡前列素氨丁三醇在合并产后出血高危因素患者中的应用[J].海南医学，2017，28（15）：2540-2541.
|
| [12] |
张亚凤，孙秋桥，黄明卉，等.年龄因素对欣母沛联合缩宫素治疗剖宫产后出血疗效的影响[J].中国妇幼健康研究，2017，28（10）：107-109.
|
| [13] |
宗璐，李春芳，黄谱，等.高龄产妇剖宫产产后出血高危因素分析及术中预防措施探讨[J].中国妇幼健康研究，2017，28（12）：1583-1585.
|
| [14] |
林文君.卡前列素氨丁三醇预防高危产妇剖宫产产后出血的应用时机分析[J].中国妇幼保健，2016，31（9）：1977-1978.
|
| [15] |
王晓芸，吴晓容，古菊梅.高龄产妇产后出血相关危险因素分析[J].现代中西医结合杂志，2016，25（5）：539-541.
|
| [16] |
王茜，王晓秋.改良B-Lynch缝合术联合阴道填纱治疗剖宫产后出血的疗效及安全性[J].中国性科学，2016，25（4）：115-117.
|
| [17] |
陈志敏，孙凯，江华.改良式B-Lynch缝合术治疗剖宫产术中出血的临床应用价值及预后观察[J].中国性科学，2017，26（2）：105-108.
|
|
|
|
